Aeolus Pharmaceuticals Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.04 |
Market Cap |
$182.5 K |
Shares Outstanding |
152.09 M |
Public Float |
- |
Address |
26361 Crown Valley Parkway Mission Viejo California 92691 United States |
Employees | - |
Website | http://www.aolsrx.com |
Updated | 07/08/2019 |
Aeolus Pharmaceuticals, Inc. engages in the business of developing platform of broad-spectrum, catalytic antioxidant compounds that protect healthy tissue from the damaging effects of oxidative stress development of medical countermeasures against biological, chemical and radiological weapons in the U. S. It also develops medical countermeasures for diseases and disorders of the central nervous system, respiratory system, autoimmune system, and oncology. |